RARA CRAFT DATABASE for FDA Medical Devices
510(k)K191748

FDA DEVICE FACTS

Genesys Spine Sacroiliac Joint Fusion System

Genesys Spine

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 26, 2019PRODUCT CODEOUR

Indications for use

The Genesys Spine Sacroiliac Joint Fusion System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. TECHNOLOGICAL COMPARISON TO PREDICATES The Genesys Spine Sacroiliac Joint Fusion System is substantially equivalent to the predicate systems in terms of:

• Indications for Use

• Physical Characteristics

• Mechanical Performance

• Principals of Operation

• Surgical Approach

• Materials

• Sterility As a result, the subject device does not introduce any new concerns of safety or effectiveness. NON-CLINICAL PERFORMANCE EVALUATION Nonclinical testing was performed on worst-case devices for the Genesys Spine Sacroiliac Joint Fusion System and demonstrated substantially equivalent performance to the predicate systems. The following mechanical tests were performed:

• Static Bending Strength (ASTM F2193-18a)

• Fatigue Bending Strength (ASTM F2193-18a)

• Torsional strength/breaking angle (ASTM F543-17)

• Insertion/removal torque (ASTM F543-17)

• Pullout force (ASTM F543-17)

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026